Purchase Order HT001418P0469
Award Date 9/21/18
Potential Completion Date 10/15/18
Potential Value $84K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
- The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and bioinformatics solutions. The contract has a ceiling value of $4,909.67 and a period of performance through April 11, 2025. The contract covers the "EXERCISE FULL AGREEMENT FOR EZ1 ADVANCED" requirement, which likely involves the provision of Qiagen's EZ1 DNA/RNA extraction equipment and...
- This federal contract award from the Defense Health Agency (DHA) is for the procurement of EZ1 DNA BLOOD 350 UL KIT TO PURIFY BLOOD, a product offered by Qiagen, LLC, a foreign-owned, for-profit manufacturer. The $39,770.00 firm fixed-price purchase order does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has an extensive portfolio of federal contract awards and grant activities supporting biomedical research, public...
- This firm fixed-price purchase order for $14,943.24 was awarded by the Defense Health Agency to Qiagen, LLC, a division of Qiagen N.V., to provide maintenance services for three QIAGEN EZ1 Advanced XL automated nucleic acid systems. The contract has an ultimate completion date of September 29, 2025. This award is not associated with a set-aside program. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and...
- This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
- This federal contract award, valued at $77,258.10, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense to Qiagen, LLC for the provision of the EZ1 Advanced XL Platform. Qiagen, LLC is a subsidiary of the Qiagen N.V. multinational biotechnology company. The contract is a firm fixed-price purchase order without a set-aside designation. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and life sciences research. Under this...
- This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...
- This federal contract award was made by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $92,973.52 firm fixed-price purchase order is for the delivery of QIAAMP DNA extraction kits. The award is not associated with a set-aside program. Qiagen is an established federal contractor, holding multiple indefinite delivery/indefinite quantity (IDIQ) contracts and blanket purchase...
- Qiagen, LLC was awarded a firm fixed-price purchase order valued at $43,679 by the Defense Health Agency on September 25, 2025, for equipment maintenance, repair, and preventative maintenance services related to Qiagen scientific equipment. The contract will be performed at Aberdeen Proving Ground, Maryland, with an ultimate completion date of September 24, 2026. This award was made without a set-aside designation, allowing Qiagen to compete in the open federal marketplace based on its...